Home/Filings/4/0001181431-12-032378
4//SEC Filing

Bouvier Eric 4

Accession 0001181431-12-032378

CIK 0001407038other

Filed

May 23, 8:00 PM ET

Accepted

May 24, 4:10 PM ET

Size

4.9 KB

Accession

0001181431-12-032378

Insider Transaction Report

Form 4
Period: 2012-05-23
Bouvier Eric
DirectorPresident, CEO
Transactions
  • Purchase

    Common Stock

    2012-05-23$3.95/sh+10,000$39,50010,000 total
Footnotes (1)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.90 to $3.99, inclusive. The reporting person undertakes to provide to BG Medicine, Inc., any security holder of BG Medicine, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in footnote (1) to this Form 4.

Issuer

BG Medicine, Inc.

CIK 0001407038

Entity typeother

Related Parties

1
  • filerCIK 0001539039

Filing Metadata

Form type
4
Filed
May 23, 8:00 PM ET
Accepted
May 24, 4:10 PM ET
Size
4.9 KB